B. Stretcher, Pharmacokinetic Optimisation of Antiretroviral Therapy in Patients with HIV Infection, Clinical Pharmacokinetics, vol.29, issue.1, pp.46-65, 1995.
DOI : 10.2165/00003088-199529010-00006

R. Hoetelmans, D. Burger, P. Meenhorst, and J. Beijnen, Pharmacokinetic individualisation of zidovudine therapy. Current state of pharmacokinetic-pharmacodynamic relationships

C. Fletcher, E. Acosta, K. Henry, L. Page, C. Gross et al., Concentration-controlled zidovudine therapy*, Clinical Pharmacology & Therapeutics, vol.337, issue.3, pp.331-339, 1998.
DOI : 10.1016/S0009-9236(98)90182-5

T. Kakuda, L. Page, P. Anderson, K. Henry, T. Schacker et al., Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and Indinavir, Antimicrobial Agents and Chemotherapy, vol.45, issue.1, pp.236-278, 2001.
DOI : 10.1128/AAC.45.1.236-242.2001

C. Goujard, M. Legrand, X. Panhard, B. Diquet, X. Duval et al., High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy, Clinical Pharmacokinetics, vol.30, issue.12, pp.1267-78, 2005.
DOI : 10.2165/00003088-200544120-00005

K. Brendel, M. Legrand, A. Taburet, G. Baron, C. Goujard et al., Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy, Fundamental and Clinical Pharmacology, vol.40, issue.3, pp.373-83, 2005.
DOI : 10.1097/00002030-200305230-00007

X. Panhard, C. Goujard, M. Legrand, A. Taburet, B. Diquet et al., Population pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART, British Journal of Clinical Pharmacology, vol.46, issue.4, pp.390-403, 2005.
DOI : 10.1002/sim.1619

B. Spire, S. Duran, M. Souville, C. Leport, F. Raffi et al., Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach, Social Science & Medicine, vol.54, issue.10, pp.1481-96, 2002.
DOI : 10.1016/S0277-9536(01)00125-3

G. Aymard, M. Legrand, N. Trichereau, and B. Diquet, Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.744, issue.2, pp.227-267, 2000.
DOI : 10.1016/S0378-4347(00)00225-5

S. Beal, Ways to fit a PK model with some data below the quantification limit, Journal of Pharmacokinetics and Pharmacodynamics, vol.28, issue.5, pp.481-504, 2001.
DOI : 10.1023/A:1012299115260

M. Lindstrom and D. Bates, Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-87, 1990.
DOI : 10.2307/2532087

J. Pinheiro and D. Bates, Mixed-effect models in S and Splus, 2000.

R. Development and C. Team, R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2005.

H. Akaike, Statistical predictor identification, Annals of the Institute of Statistical Mathematics, vol.3, issue.1, pp.203-217, 1973.
DOI : 10.1007/BF02506337

S. Gitterman, G. Drusano, M. Egorin, and H. Standiford, Population pharmacokinetics of zidovudine, Clinical Pharmacology and Therapeutics, vol.48, issue.2, pp.161-168, 1990.
DOI : 10.1038/clpt.1990.131

F. Mentré, S. Escolano, B. Diquet, J. Golmard, and A. Mallet, Clinical pharmacokinetics of zidovudine: inter and intraindividual variability and relationship to long term efficacy and toxicity, European Journal of Clinical Pharmacology, vol.I, issue.2, pp.397-407, 1993.
DOI : 10.1007/BF00315509

C. Horton, M. Dudley, S. Kaul, K. Mayer, K. Squires et al., Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex, Antimicrobial Agents and Chemotherapy, vol.39, issue.10, pp.2309-2324, 1995.
DOI : 10.1128/AAC.39.10.2309

G. Harb, J. Mandema, T. Delahunty, N. Benowitz, R. Coleman et al., Population Pharmacokinetics of Didanosine in Patients with Human Immunodeficiency Virus Infection, Journal of Infectious Diseases, vol.173, issue.1, p.273, 1996.
DOI : 10.1093/infdis/173.1.273

K. Moore, G. Yuen, E. Hussey, G. Pakes, J. Eron et al., Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials, Antimicrob Agents Chemother, vol.43, issue.12, pp.3025-3034, 1999.

S. Weller, K. Radomski, Y. Lou, and D. Stein, Population Pharmacokinetics and Pharmacodynamic Modeling of Abacavir (1592U89) from a Dose-Ranging, Double-Blind, Randomized Monotherapy Trial with Human Immunodeficiency Virus-Infected Subjects, Antimicrobial Agents and Chemotherapy, vol.44, issue.8, pp.2052-60, 2000.
DOI : 10.1128/AAC.44.8.2052-2060.2000

X. Zhou, L. Sheiner, D. Aquila, R. Hughes, M. Hirsch et al., Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators, Antimicrob Agents Chemother, vol.43, issue.1, pp.121-129, 1999.

V. Jullien, J. Tréluyer, E. Rey, P. Jaffray, A. Krivine et al., Population Pharmacokinetics of Tenofovir in Human Immunodeficiency Virus-Infected Patients Taking Highly Active Antiretroviral Therapy, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3361-3367, 2005.
DOI : 10.1128/AAC.49.8.3361-3366.2005

J. Angel, E. Hussey, S. Hall, K. Donn, D. Morris et al., Pharmacokinetics of 3TC (GR109714X) Administered With and Without Food to HIV-infected Patients, Drug Investigation, vol.4, issue.2, pp.70-74, 1993.
DOI : 10.1007/BF03258455

K. Moore, S. Shaw, A. Laurent, P. Lloyd, B. Duncan et al., Lamivudine/Zidovudine as a Combined Formulation Tablet: Bioequivalence Compared with Lamivudine and Zidovudine Administered Concurrently and the Effect of Food on Absorption, The Journal of Clinical Pharmacology, vol.277, issue.Suppl. 2, pp.593-605, 1999.
DOI : 10.1177/00912709922008209

R. Aarnoutse, J. Schapiro, C. Boucher, Y. Hekster, and D. Burger, Therapeutic Drug Monitoring, Drugs, vol.40, issue.8, pp.741-53, 2003.
DOI : 10.2165/00003495-200363080-00002

G. Drusano, G. Yuen, J. Lambert, M. Seidlin, R. Dolin et al., Relationship between Dideoxyinosine Exposure, CD4 Counts, and p24 Antigen Levels in Human Immunodeficiency Virus Infection, Annals of Internal Medicine, vol.116, issue.7, pp.562-568, 1992.
DOI : 10.7326/0003-4819-116-7-562

P. Sasomsin, F. Mentré, B. Diquet, F. Simon, and F. Brun-vezinet, Relationship between exposure to zidovudine and decrease of P24 antigenemia in HIV-infected patients in monotherapy, Fundamental and Clinical Pharmacology, vol.63, issue.5
DOI : 10.1016/S0378-4347(00)83399-X